search
Back to results

Mnaual Therapy in Treatment of Carpal Tunnel Syndrome

Primary Purpose

Carpal Tunnel Syndrome

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Manual therapy
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome

Eligibility Criteria

45 Years - 55 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pain and paresthesia at median nerve distribution ,positive tinel sign and positive phalen sign.

Exclusion Criteria:

  • Any sensory and/or motor deficit in either ulnar or radial nerve
  • age greater than 45 years .
  • male sex.

Sites / Locations

  • Sahar

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Neuro dynamic

desensitization

Arm Description

Neurodynamic techniques.

Desensitization maneuvers

Outcomes

Primary Outcome Measures

PAIN and function
Boston carpal tunnel questionnaire (BCTQ) measure function and pain
muscle strength
measured by dynamometer to measure cylindrical grip and pincer grip

Secondary Outcome Measures

Full Information

First Posted
November 15, 2021
Last Updated
July 18, 2023
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT05150912
Brief Title
Mnaual Therapy in Treatment of Carpal Tunnel Syndrome
Official Title
Manual Therapy Based on Neurodynamic Techniques Versus Manual Therapy Including Desensitization Maneuvers With One Year Follow-up :Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
February 26, 2020 (Actual)
Primary Completion Date
September 24, 2021 (Actual)
Study Completion Date
May 24, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
2 groups of patients randomized for the treatment.
Detailed Description
One group treated with neurodynamic techniques and the the other with the desensitization maneuvers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
412 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Neuro dynamic
Arm Type
Active Comparator
Arm Description
Neurodynamic techniques.
Arm Title
desensitization
Arm Type
Active Comparator
Arm Description
Desensitization maneuvers
Intervention Type
Other
Intervention Name(s)
Manual therapy
Intervention Description
strching neck
Primary Outcome Measure Information:
Title
PAIN and function
Description
Boston carpal tunnel questionnaire (BCTQ) measure function and pain
Time Frame
after one year
Title
muscle strength
Description
measured by dynamometer to measure cylindrical grip and pincer grip
Time Frame
3 month

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pain and paresthesia at median nerve distribution ,positive tinel sign and positive phalen sign. Exclusion Criteria: Any sensory and/or motor deficit in either ulnar or radial nerve age greater than 55 years . male sex.
Facility Information:
Facility Name
Sahar
City
Cairo
ZIP/Postal Code
11431
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Mnaual Therapy in Treatment of Carpal Tunnel Syndrome

We'll reach out to this number within 24 hrs